Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 31 Records) |
| Query Trace: Lung Neoplasms and meta-analysis and Kras[original query] |
|---|
| [Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2010 Sep 13 (9): 882-91. Han Chengbo, Zou Huawei, Ma Jietao, Zhou Yang, Zhao Jianz |
| Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer. PloS one 2013 8 (1): 1. Li Y, Li Y, Yang T, Wei S, Wang J, Wang M, Wang Y, Zhou Q, Liu H, Chen J |
| The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis. OncoTargets and therapy 2014 7 1487-96. Ying Hou-Qun, Wang Feng, He Bang-Shun, Pan Yu-Qin, Gao Tian-Yi, Xu Ye-Qiong, Li Rui, Deng Qi-Wen, Sun Hui-Lin, Wang Shu-K |
| Meta-analysis of epidermal growth factor receptor and KRAS gene status between primary and corresponding metastatic tumours of non-small cell lung cancer. Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Jan 27 (1): 30-9. Wang S, Wang |
| KRAS Mutation as a Biomarker for Survival in Patients with Non-Small Cell Lung Cancer, A Meta-Analysis of 12 Randomized Trials. Asian Pacific journal of cancer prevention : APJCP 2015 16 (10): 4439-45. Ying Min, Zhu Xiao-Xia, Zhao Yang, Li Dian-He, Chen Long-H |
| The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis. Medical oncology (Northwood, London, England) 2015 Mar 32 (3): 61. Zhang Yaxiong, Fang Wenfeng, Yan Yue, Wang Mengyao, Kang Shiyang, Sheng Jin, Zhan Jianhua, Chen Nan, Hong Shaodong, Yang Yunpeng, Ma Yuxiang, He Dacheng, Qin Tao, Zhou Ting, Tang Yanna, He Xiaobo, Liang Wenhua, Zhang |
| Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis. Journal of cancer research and clinical oncology 2015 Aug 141 (8): 1427-39. Ying Min, Zhu Xiaoxia, Chen Kexu, Sha Zhou, Chen Longh |
| rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis. Journal of cancer research and therapeutics 0 12 (2): 699-704. Zhang Shi-Yan, Shi Ji |
| Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Oncotarget 2016 Jun . Ai Bo, Liu Huiquan, Huang Yu, Peng Pi |
| KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies. Oncotarget 2016 Jan . Pan Wei, Yang Yan, Zhu Hongcheng, Zhang Youcheng, Zhou Rongping, Sun Xinch |
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers. Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134. Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy |
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes. Journal of thoracic disease 2017 Aug 9 (8): 2560-2571. Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang |
| The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. PloS one 2017 12 (8): e0182562. Zhuang Rongyuan, Li Song, Li Qian, Guo Xi, Shen Feng, Sun Hong, Liu Tians |
| Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 2017 May 8 (20): 33922-33932. Fan Gaowei, Zhang Kuo, Ding Jiansheng, Li Jinmi |
| Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis. Cancer management and research 2018 9 10 3393-3404. Zhang Shi-Ming, Zhu Qing-Ge, Ding Xiao-Xiao, Lin Song, Zhao Jing, Guan Lei, Li Ting, He Bing, Zhang Hu-Q |
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis. Oncotarget 2018 Jan 9 (7): 7684-7699. Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K |
| Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials. Oncoimmunology 2018 12 7 (12): e1396403. Huang Qingyuan, Zhang Hua, Hai Josephine, Socinski Mark A, Lim Eric, Chen Haiquan, Stebbing Just |
| PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs. Cancer biology & medicine 2018 Nov 15 (4): 434-442. Bai Yuchen, Chen Xiaoxia, Hou Likun, Qian Jun, Jiang Tao, Zhou Caicun, Ciebiada Maci |
| Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis. BioMed research international 2020 2020 2380124. Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in oncology 2021 5 11 680191. Qian Xiaohan, Fu Mengjiao, Zheng Jing, Zhou Jianya, Zhou Jianyi |
| Risk factors for brain metastases in patients with non-small cell lung cancer: a meta-analysis of 43 studies. Annals of palliative medicine 2021 4 10 (4): 3657-3672. Chen Shanshan, Hua Xin, Jia Jinfang, Wu Ying, Wei Shuzhen, Xu Lu, Han Shuhua, Zhang Hongming, Zhu Xiao |
| Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis. Medicine 2021 Mar 100 (10): e19713. Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa |
| Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thoracic cancer 2021 Feb . Kobayashi Nobuaki, Katakura Seigo, Kamimaki Chisato, Somekawa Kohei, Fukuda Nobuhiko, Tanaka Katsushi, Watanabe Keisuke, Horita Nobuyuki, Hara Yu, Piao Hongmei, Kaneko Takes |
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101. Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li |
| Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis. Thrombosis research 2022 3 213 47-56. Abufarhaneh Mohammed, Pandya Rudra Kashyap, Alkhaja Ahmed, Iansavichene Alla, Welch Stephen, Lazo-Langner Alejand |
| Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis. medRxiv : the preprint server for health sciences 2023 11 . Cheng Chen, Michael P Douglas, Meera V Ragavan, Kathryn A Phillips, Jeroen P Jans |
| Efficacy and toxicity of drugs targeting KRAS mutation in non-small cell lung cancer: a meta-analysis. Expert review of anticancer therapy 2023 11 . Wei Luo, Jing Zhu, Wenxue Zhang, Airu Yu, Wei Zhou, Ke |
| Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Diagnostics (Basel, Switzerland) 2023 10 13 (19): . Durgesh Wankhede, Christophe Bontoux, Sandeep Grover, Paul Hofm |
| Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis. Molecular diagnosis & therapy 2024 8 . Cheng Chen, Michael P Douglas, Meera V Ragavan, Kathryn A Phillips, Jeroen P Jans |
- Page last reviewed:Feb 1, 2024
- Content source: